Demant A/S (CPH: DEMANT)
Denmark
· Delayed Price · Currency is DKK 258.80
-6.60 (-2.49%)
Dec 19, 2024, 4:59 PM CET
Demant Revenue
Demant had revenue of 11.09B DKK in the half year ending June 30, 2024, with 16.74% growth. This brings the company's revenue in the last twelve months to 22.84B, up 9.25% year-over-year. In the year 2023, Demant had annual revenue of 22.44B with 13.89% growth.
Revenue (ttm)
22.84B
Revenue Growth
+9.25%
P/S Ratio
2.55
Revenue / Employee
1.06M
Employees
21,623
Market Cap
57.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 22.44B | 2.74B | 13.89% |
| Dec 31, 2022 | 19.71B | 1.80B | 10.05% |
| Dec 31, 2021 | 17.91B | 3.44B | 23.75% |
| Dec 31, 2020 | 14.47B | -477.00M | -3.19% |
| Dec 31, 2019 | 14.95B | 1.01B | 7.24% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk A/S | 270.58B |
| Coloplast A/S | 27.03B |
| Genmab A/S | 19.84B |
| Zealand Pharma A/S | 76.87M |
| H. Lundbeck A/S | 21.44B |
| H. Lundbeck A/S | 21.44B |
| ALK-Abelló A/S | 5.38B |
| Ambu A/S | 5.39B |